Pay in 4 interest-free payments of $6.51 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Any material this article references is for laboratory research use only
Sara Suliman, Consultant Endocrinologist and Diabetologist at Imperial College London Diabetes & Endocrine Centre (M42)
PT-141 is supplied by Eternal Peptides strictly for laboratory research use only
Tissue-specific glucocorticoid reactivating enzyme, 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1)a promising drug target for the treatment of metabolic syndrome
Poltica de devoluciones: Solo por defectos de fabricacin (Ley 1480 de 2011)
Cardiovascular outcome trials evaluating novel agents that target multiple pathways including combinations of GLP-1 agonism, GIP agonism, glucagon receptor agonism and amylin analogues are ongoing and will help define the next generation of obesity treatments
US$ 28.97
US$ 20.37
US$ 25.30
US$ 27.17
US$ 27.96
US$ 22.58
